Evidence for the presence of tumor peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000032:analysis / Q000378:metabolism*; D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001681:Biological Assay; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy / Q000378:metabolism* / Q000532:radiotherapy / Q000652:urine; D003346:Corticotropin-Releasing Hormone / Q000032:analysis*; D003907:Dexamethasone / Q000627:therapeutic use; D004586:Electrophoresis; D005246:Feedback; D006729:Hormones, Ectopic / Q000378:metabolism*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000532:radiotherapy / Q000652:urine; D008239:Lysine / Q000494:pharmacology; D008797:Metyrapone; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000032:analysis* / Q000302:isolation & purification; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D010455:Peptides / Q000032:analysis* / Q000302:isolation & purification; D051381:Rats; D014667:Vasopressins / Q000494:pharmacology
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000596:Amino Acids; D006729:Hormones, Ectopic; D009363:Neoplasm Proteins; D010455:Peptides; D014667:Vasopressins; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D008239:Lysine; D008797:Metyrapone